by University College London Credit: Unsplash/CC0 Public Domain A world-first treatment for Creutzfeldt-Jakob disease (CJD), developed by scientists at the Medical Research Council (MRC) Prion Unit at UCL, has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust. CJD is a rare but devastating...
